Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, May 26 2026 UPDATED 9:22 AM

Full Issue

US Will Shield Drugmakers Who Make Hantavirus Treatment; Patient In Quarantine Tests Positive

Axios reported that HHS Secretary Robert F. Kennedy Jr. extended legal protections through July 18 to develop favipiravir, an experimental antiviral used to manage flu and other infections, according to a Federal Register filing. The move drew criticism from MAHA supporters. Meanwhile, a passenger on the MV Hondius who was in quarantine in Spain has tested positive.

Axios: Kennedy Offers Legal Shield To Develop Hantavirus Treatment

Health Secretary Robert F. Kennedy Jr. is offering to shield drugmakers from legal liability as an incentive to develop treatments for the Andes hantavirus that caused a deadly outbreak on a cruise ship this month. (Bettelheim, 5/26)

NBC News: Spanish Government Confirms New Case Of Hantavirus

The Spanish government said Monday it has confirmed a new case of hantavirus connected to the cruise ship MV Hondius, which became the center of an outbreak that killed three people earlier this month. A Spanish national who has been in preventive quarantine at a hospital in Madrid tested positive for the virus, the Health Ministry said in a statement. (Silva, 5/25)

The Hill: WHO: Hantavirus Outbreak Is 'Stable'

World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus on Sunday said the hantavirus “situation is stable for now.” Tedros provided an update stating that WHO has reported 12 cases of hantavirus and three deaths, with no other confirmed deaths since May 2. The outbreak is believed to have originated from South America after infected travelers boarded the cruise ship MV Hondius earlier this month. (Mancini, 5/24)

The Guardian: Ebola And Hantavirus Outbreaks Prompt Raft Of Conspiracy Theories In Divided US

Hantavirus and Ebola outbreaks carry with them familiar attendants in the US: extreme conspiracy theories about a planned pandemic, or “plandemic”, designed to upend midterm elections or push new vaccines or any one of a myriad of wild ideas. ... The hantavirus outbreak, which began on a cruise ship in the South Atlantic, killing three passengers and causing at least 11 to test positive, carries its own set of baggage in the form of conspiracy theories: passengers were crisis actors, or it was caused by Covid vaccines and Bill Gates, or perhaps it was an Israeli false flag operation and can be cured by the antiviral horse de-wormer ivermectin. (Helmore, 5/25)

Roll Call: Hantavirus, Ebola Highlight Political Division Over Disease 

The Trump administration’s shake-up of the United States’ public health apparatus in the wake of the COVID-19 pandemic has public health experts concerned about the country’s ability to respond to emerging disease outbreaks like hantavirus and Ebola. Whether that’s a concern for Congress, however, often depends on the member’s party — a reaction that should be familiar to anyone who lived through the highly partisan response to the pandemic. (Cohen and Behrmann, 5/26)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 26
  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF